Global Precision Medicine IT Solutions for Oncology—Companies to Action, 2017

Global Precision Medicine IT Solutions for Oncology—Companies to Action, 2017

Early Movers Expect to Facilitate Evidence-Based Cancer Care

RELEASE DATE
24-Nov-2017
REGION
Global
Research Code: K1E9-01-00-00-00
SKU: HC02927-GL-MR_21171
$3,000.00
In stock
SKU
HC02927-GL-MR_21171
$3,000.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Author: Koustav Chatterjee, Natasha Gulati, and Daniel Ruppar

Definition

Precision medicine for oncology is defined as patient-specific cancer care that is aided by a targeted software suite. The realm of precision medicine is determined by providers' willingness and ability to capture and normalize disparate patient data - including clinical, socioeconomic, behavioral, and genomic - to identify evidence-based treatments that are ideal for each patient.

Report Outlook

This report profiles vendors that are offering promising, disruptive, and pioneering solutions across diverse domains in precision medicine for oncology. It brings the most recent and successful and/or high-potential companies to light. The focus has been to identify vendors that bring in the advantage purely in terms of analytics - not other components of data management and meaningful use. These companies create extraordinary value for their internal and external stakeholders by showcasing visionary leadership and implementing industry best practices, and through business model innovation.

Market Snapshot

Healthcare IT ecosystems around the world are not adequately equipped to facilitate seamless data interoperability across the care continuum, which is fundamental for enabling precision medicine. For example, even in the United States - arguably a progressive and technologically sophisticated digital health market - the regulatory framework (e.g., CMS, ONC, HHS*) fails to introduce clear mandates that safeguard the privacy of patients willing to share medical data for the Precision Medicine Initiative; outline incentive guidelines for patients accepting precision medicine approaches; introduce reimbursement programs for providers investing in precision medicine systems; and encourage consideration of patients‘ sociobehavioral state to adjust treatment pathways. As a result, most providers have yet to realize tangible ROIs from precision medicine pilots.
Poor support from ecosystem-level partners (incumbent EHR, RCM, HIE, and clinical decision support system vendors) coupled with a lack of ROI evidence validates that the precision medicine market is still in its infancy.

Despite the low levels of supply-side maturity, more providers will embrace precision medicine, especially in the United States, to improve patient outcomes and rationalize corporate profitability due to mandatory or voluntary involvement in value-based care and the Precision Medicine Initiative. They will depend on external specialist firms to develop proprietary tools or introduce third-party platforms.

Precision medicine IT vendors are going to leverage this renewed market interest to facilitate visionary patient services, supported by the latest clinical and academic evidence.

Key Takeaway

Top vendors will digitize and automate the process of patient data capture, analysis, and reporting. They will help generate patient-specific treatment options and recommend potential recovery plans based on each patient‘s clinical and genomic profiles. Physicians will be able to validate these auto-generated clinical pathways based on their experience and knowledge.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Methodology

Scope and Segmentation

Global Precision Medicine IT Market Snapshot

Global Precision Medicine IT Solutions for Oncology—Analysis of Companies to Action

Strategic Imperatives for Industry Stakeholders to Explore Precision Medicine

Precision Medicine—Regional Market Overview

Precision Medicine—Future Impact on Healthcare

Precision Medicine—Strategic Imperatives for Success and Growth

Industry Convergence Driving Disruption and Innovation

Convergence in Healthcare Creates Both Opportunities and Threats

Frost & Sullivan Companies to Action Have the Potential to Disrupt Current Healthcare Industry Paradigms

Digital Health Benefits from Broader Industry Convergence

Digital Health Priorities

Digital Health Market Segmentation and Convergence

What is Precision Medicine?

Market Challenges, Opportunities, and Concerns

Current State of Precision Medicine Adoption

Key Data Sources for Precision Medicine

Impact of Precision Medicine on Oncology

Impact of Key Market Influencers

Operational Architecture of Precision Medicine for Oncology

Stakeholders’ Digital Health Solutions

Digital Health Solutions Applicable Across the Care Continuum

Digital Health Companies Supporting Precision Medicine for Oncology—Vendor Landscape

Top Industry Needs and Vendor Strategies

Precision Medicine IT Solutions for Oncology—C2A Key Findings

2bPrecise (Allscripts)

Cerner

GenomOncology

IBM Watson Health

N-of-One

NantHealth

Navican (an Intermountain Healthcare Company)

Quest Diagnostics

Royal Philips

Via Oncology

Precision Medicine—Future Impact on Healthcare

Precision Medicine—Strategic Imperatives for Success and Growth

Legal Disclaimer

List of Vendors Assessed

Abbreviation List

List of Figures
  • 1. Digital Health C2A: Digital Health Solutions for Diagnosis—Precision Medicine IT Solutions for Oncology, Global, 2017
  • 2. Digital Health C2A: Digital Health Solutions for Treatment—Precision Medicine IT Solutions for Oncology, Global, 2017
  • 3. Digital Health C2A: Digital Health Solutions for Prevention—Precision Medicine IT Solutions for Oncology, Global, 2017
  • 4. Digital Health C2A: Select List of Vendors Assessed—Precision Medicine IT Solutions for Oncology, Global, 2017
List of Charts
  • 1. Digital Health C2A: Vendors Profiled in this Research—Precision Medicine IT Solutions for Oncology, Global, 2017
  • 2. Digital Health C2A: Vendors’ Best Practices—Precision Medicine IT Solutions for Oncology, Global, 2017
  • 3. Digital Health C2A: Shortlisted Vendors' Ability to Address Industry Needs—Precision Medicine IT Solutions for Oncology, Global, 2017
  • 4. Digital Health C2A: Indicative Value of Precision Medicine by Industry Stakeholder—Precision Medicine IT Solutions for Oncology, US, 2017
  • 5. Digital Health C2A: Precision Medicine Percent Revenue Contribution by Region, Global, 2016
  • 6. Digital Health C2A: C2A Value Creators, Global, 2017
  • 7. Digital Health C2A: Digital Health Market Segmentation and Convergence, Global, 2017
  • 8. Digital Health C2A: Challenges, Opportunities, and Concerns—Precision Medicine IT Solutions for Oncology, Global, 2017
  • 9. Digital Health C2A: Precision Medicine Adoption as per HIMSS Analytics Survey, US, 2016 and 2017
  • 10. Adoption of Precision Medicine Approaches by End User, US, 2017
  • 11. Digital Health C2A: Precision Medicine Key Data Sources, Global, 2017
  • 12. Digital Health C2A: Impact of Key Market Influencers—Precision Medicine IT Solutions for Oncology, Global, 2017
  • 13. Digital Health C2A: Stakeholders’ Digital Health Solutions—Precision Medicine IT Solutions for Oncology, Global, 2017
  • 14. Digital Health C2A: Shortlisted Vendors' Ability to Address Industry Needs—Precision Medicine IT Solutions for Oncology Global, 2017
Related Research
Healthcare data analytics refers to information technology (IT) solutions and services that mine structured and unstructured digital content generated by healthcare industry stakeholders with the goal of achieving a predefined outcome. The healthcare industry is witnessing a redefinition of “value” through the changing expectations of care quality, reimbursement models, and patient experience. To deliver new forms of value, industry stakeholders need a far more granular dissection of data; payers, providers, and pharmaceutical and medical technology companies are taking this move very seriously. To support these rapidly changing stakeholders, data analytics vendors are bringing new and innovative solutions to the market that can help solve specific business issues around developing new solutions, revenue streams, operating models, and target customers. This report profiles vendors that are offering promising, disruptive, and pioneering solutions across diverse domains in precision medicine for oncology. It brings the most recent and successful and/or high-potential companies to light. The focus has been to identify vendors that bring in the advantage purely in terms of analytics—not other components of data management and meaningful use. These companies create extraordinary value for their internal and external stakeholders by showcasing visionary leadership and implementing industry best practices, and through business model innovation. Precision medicine for oncology is defined as patient-specific cancer care that is aided by a targeted software suite. The realm of precision medicine is determined by providers’ willingness and ability to capture and normalize disparate patient data—including clinical, socioeconomic, behavioral, and genomic—to identify evidence-based treatments that are ideal for each patient. Key questions this study will answer: • What are the current growth opportunities in precision medicine for oncology? What is the impact of the exter
More Information
No Index No
Podcast No
Table of Contents || Methodology~ || Scope and Segmentation~ | Executive Summary~ || Global Precision Medicine IT Market Snapshot~ || Global Precision Medicine IT Solutions for Oncology—Analysis of Companies to Action~ || Strategic Imperatives for Industry Stakeholders to Explore Precision Medicine~ || Precision Medicine—Regional Market Overview~ || Precision Medicine—Future Impact on Healthcare~ || Precision Medicine—Strategic Imperatives for Success and Growth~ | Companies to Action Overview~ || Industry Convergence Driving Disruption and Innovation~ || Convergence in Healthcare Creates Both Opportunities and Threats~ || Frost & Sullivan Companies to Action Have the Potential to Disrupt Current Healthcare Industry Paradigms~ | Digital Health Industry Snapshot~ || Digital Health Benefits from Broader Industry Convergence~ || Digital Health Priorities~ || Digital Health Market Segmentation and Convergence~ | Precision Medicine for Oncology Market Overview~ || What is Precision Medicine?~ || Market Challenges, Opportunities, and Concerns~ || Current State of Precision Medicine Adoption~ || Key Data Sources for Precision Medicine~ || Impact of Precision Medicine on Oncology~ || Impact of Key Market Influencers~ || Operational Architecture of Precision Medicine for Oncology~ || Stakeholders’ Digital Health Solutions~ || Digital Health Solutions Applicable Across the Care Continuum~ || Digital Health Companies Supporting Precision Medicine for Oncology—Vendor Landscape~ || Top Industry Needs and Vendor Strategies~ || Precision Medicine IT Solutions for Oncology—C2A Key Findings~ | C2A Profiles~ || 2bPrecise (Allscripts)~ || Cerner~ || GenomOncology~ || IBM Watson Health~ || N-of-One~ || NantHealth~ || Navican (an Intermountain Healthcare Company)~ || Quest Diagnostics~ || Royal Philips~ || Via Oncology~ | The Last Word~ || Precision Medicine—Future Impact on Healthcare~ || Precision Medicine—Strategic Imperatives for Success and Growth~ || Legal Disclaimer~ | Appendix~ || List of Vendors Assessed~ || Abbreviation List~ | The Frost & Sullivan Story~
List of Charts and Figures 1. Digital Health C2A: Digital Health Solutions for Diagnosis—Precision Medicine IT Solutions for Oncology, Global, 2017~ 2. Digital Health C2A: Digital Health Solutions for Treatment—Precision Medicine IT Solutions for Oncology, Global, 2017~ 3. Digital Health C2A: Digital Health Solutions for Prevention—Precision Medicine IT Solutions for Oncology, Global, 2017~ 4. Digital Health C2A: Select List of Vendors Assessed—Precision Medicine IT Solutions for Oncology, Global, 2017~| 1. Digital Health C2A: Vendors Profiled in this Research—Precision Medicine IT Solutions for Oncology, Global, 2017~ 2. Digital Health C2A: Vendors’ Best Practices—Precision Medicine IT Solutions for Oncology, Global, 2017~ 3. Digital Health C2A: Shortlisted Vendors' Ability to Address Industry Needs—Precision Medicine IT Solutions for Oncology, Global, 2017~ 4. Digital Health C2A: Indicative Value of Precision Medicine by Industry Stakeholder—Precision Medicine IT Solutions for Oncology, US, 2017~ 5. Digital Health C2A: Precision Medicine Percent Revenue Contribution by Region, Global, 2016~ 6. Digital Health C2A: C2A Value Creators, Global, 2017~ 7. Digital Health C2A: Digital Health Market Segmentation and Convergence, Global, 2017~ 8. Digital Health C2A: Challenges, Opportunities, and Concerns—Precision Medicine IT Solutions for Oncology, Global, 2017~ 9. Digital Health C2A: Precision Medicine Adoption as per HIMSS Analytics Survey, US, 2016 and 2017~ 10. Adoption of Precision Medicine Approaches by End User, US, 2017~ 11. Digital Health C2A: Precision Medicine Key Data Sources, Global, 2017~ 12. Digital Health C2A: Impact of Key Market Influencers—Precision Medicine IT Solutions for Oncology, Global, 2017~ 13. Digital Health C2A: Stakeholders’ Digital Health Solutions—Precision Medicine IT Solutions for Oncology, Global, 2017~ 14. Digital Health C2A: Shortlisted Vendors' Ability to Address Industry Needs—Precision Medicine IT Solutions for Oncology Global, 2017~
Author Koustav Chatterjee
Industries Healthcare
WIP Number K1E9-01-00-00-00
Keyword 1 Precision Medicine
Keyword 2 Oncology
Is Prebook No